Science and innovation are the lifeblood of our company. But we’re
doing more than developing medicines that perform well in the
lab—we’re elevating the current standard of care to bring greater
benefits to our patients.
Published 1,150+ papers
AbbVie scientists in the medical research community published more
than 1,150 papers
in 2019 - allowing others to build on scientific knowledge we’ve developed.
different medical compounds in 86 different currently being
in clinical studies across the UK
*Data as of Jan 2021
patients participating in an AbbVie clinical trials in the UK
*Data as of Dec 2020
Over £11.5 million
was invested in UK Clinical trial activity throughout 2019
Over £50 million
has been invested in Clinical Trial activity in the UK since 2014
Bringing Better Solutions to Patients
By investing in groundbreaking technologies and platforms, our goal is to drive innovation within our pipeline and deliver better solutions to patients.
invested to advance science
*Excluding specified items
of medicines in our pipeline are considered first-in-kind
scientists working globally to make a difference